Securities code: Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) Announcement No.: 2022018
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317)
Announcement of resolutions of the 10th meeting of the 7th board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) (hereinafter referred to as “the company”) the notice of the 10th meeting of the 7th board of supervisors was sent to all supervisors in person on February 22, 2022, and the meeting was held by on-site voting in the company’s conference room on March 1, 2022. There are 3 supervisors who should attend the meeting and 3 supervisors who actually attended the meeting. The meeting was presided over by Mr. Luo RIKANG, chairman of the board of supervisors of the company, and the Secretary of the board of directors attended the meeting as nonvoting delegates. The convening and convening of this meeting comply with the relevant provisions of laws, regulations and the articles of association. After careful deliberation and voting by open ballot, the attending supervisors made the following resolutions:
1、 The proposal on adjusting the list of incentive objects and the number of awards of the company’s restricted stock incentive plan in 2022 was reviewed and approved.
After review, two incentive objects resigned for personal reasons. According to the relevant provisions of the company’s 2022 restricted stock incentive plan (Draft) and the authorization of the company’s first extraordinary general meeting in 2022, it is agreed that the company will cancel their qualification to participate in the 2022 restricted stock incentive plan. The adjusted incentive objects meet the incentive object conditions specified in relevant laws and regulations, and the subject qualification is legal and effective. It is agreed that the company will adjust the list of incentive objects and the number of awards of the restricted stock incentive plan in 2022, and the incentive objects of the restricted stock incentive plan in 2022 will be adjusted from 79 to 77, The total number of restricted shares granted was adjusted from 5840000 shares to 5780000 shares.
In addition to the above adjustments, other contents of the restricted stock incentive plan implemented by the company this time are consistent with the company’s 2022 restricted stock incentive plan (Draft) approved by the company’s first extraordinary general meeting in 2022. Voting results: 3 in favor, 0 against and 0 abstention.
2、 Reviewed and approved the “on granting restrictions to the incentive objects of the company’s restricted stock incentive plan in 2022”
Securities code: Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) Announcement No.: 2022018
The proposal of controlling shares.
After review, the board of supervisors believes that:
1. Except that some employees are disqualified from participating in the company’s 2022 restricted stock incentive plan due to personal reasons, the incentive objects granted with restricted stock this time are consistent with the incentive objects specified in the company’s 2022 restricted stock incentive plan (Draft) approved by the company’s first extraordinary general meeting in 2022. 2. The incentive objects granted with restricted shares this time have the qualifications specified in the company law, the securities law, the articles of association and other laws, regulations and normative documents, and meet the incentive object conditions specified in the measures for the administration of equity incentive of listed companies and other documents, There is no circumstance that the listed company shall not be the incentive object as stipulated in Article 8 of the measures for the administration of equity incentive of listed companies. The incentive object does not include the company’s independent directors, supervisors, shareholders or actual controllers who individually or jointly hold more than 5% of the shares of the listed company and their spouses, parents and children. The subject qualification of the incentive object granted restricted shares this time is legal and effective, and meets the conditions for granting restricted shares.
3. The grant date determined by the board of directors is in accordance with the measures for the administration of equity incentive of listed companies and the provisions on the grant date in this incentive plan. Neither the company nor the incentive objects granted this time are allowed to grant restricted shares, and the conditions set by the company’s incentive plan for the incentive objects to be granted restricted shares have been met.
It is agreed that the granting date of the company’s restricted stock incentive plan in 2022 is March 1, 2022, and 5780000 restricted shares are granted to 77 incentive objects.
Voting results: 3 in favor, 0 against and 0 abstention.
Documents for future reference
The resolution of the board of supervisors signed by the attending supervisors.
It is hereby announced.
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) board of supervisors March 1, 2002
